|
HBV | Abstract Library |
|
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
2. | What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis |
|
Liver Int. 2024 Nov;44(11):2890-2903. doi: 10.1111/liv.16064. Epub 2024 Aug 29.
Ciro Celsa 1 2, Giacomo E M Rizzo 1 3 4, Gabriele Di Maria 5, Marco Enea 5, Marco Vaccaro 6, Gabriele Rancatore 1 4, Pietro Graceffa 1, Giuseppe Falco 1, Salvatore Petta 1, Giuseppe Cabibbo 1, Vincenza Calvaruso 1, Antonio Craxì 1, Calogero Cammà 1, Vito Di Marco 1
|
|
|
|
|
|
|
5. | Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process |
|
Liver Int. 2024 Oct;44(10):2773-2792. doi: 10.1111/liv.16048. Epub 2024 Jul 30.
Michael Basic 1 2, Keerthihan Thiyagarajah 1 2, Mirco Glitscher 2, Anja Schollmeier 2, Qingyan Wu 2, Esra Görgülü 1 2, Pia Lembeck 2 3, Jannik Sonnenberg 3, Julia Dietz 1, Fabian Finkelmeier 1, Michael Praktiknjo 3, Jonel Trebicka 3, Stefan Zeuzem 1, Christoph Sarrazin 1 4, Eberhard Hildt 2 5, Kai-Henrik Peiffer 1 2 3
|
|
|
|
|
7. | A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir |
|
J Clin Virol. 2024 Oct:174:105711. doi: 10.1016/j.jcv.2024.105711. Epub 2024 Jun 28.
Sheila F Lumley 1, Marion Delphin 2, Jolynne F Mokaya 3, Cedric C S Tan 2, Emily Martyn 2, Motswedi Anderson 4, Ka Chun Li 2, Elizabeth Waddilove 2, Gloria Sukali 5, Louise O Downs 6, Khadija Said 2, Dorcas Okanda 7, Cori Campbell 8, Eli Harriss 9, Yusuke Shimakawa 10, Philippa C Matthews 11
|
|
|
|
|
|
|
|
|
|
|
|
|
13. | Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022 |
|
MMWR Morb Mortal Wkly Rep. 2024 Jul 25;73(29):648-655. doi: 10.15585/mmwr.mm7329a3.
Mary M Alleman, Leandro Soares Sereno, Alvaro Whittembury, Xi Li, Marcela Contreras, Carmelita Pacis-Tirso, Martha Velandia Gonzalez, Karen Broome, Sandra Jones, Daniel Salas, Monica Alonso, Rania A Tohme, Annemarie Wasley
|
|
|
|
|
|
|
16. | High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy |
|
Liver Int. 2024 Jul 15. doi: 10.1111/liv.16029. Online ahead of print.
Simon J Hume 1 2 3, Danny K Wong 4, Man-Fung Yuen 4, Kathy Jackson 3, Sara Bonanzinga 3, Sara Vogrin 2, Samuel A L Hall 1 2, Gareth S Burns 5, Paul V Desmond 1, Vijaya Sundararajan 1 2, Dilip Ratnam 6, Miriam T Levy 7, John S Lubel 8, Amanda J Nicoll 9, Simone I Strasser 10, William Sievert 6, Meng C Ngu 11, Marie Sinclair 12, Christopher Meredith 13, Gail Matthews 14, Peter A Revill 3, Margaret Littlejohn 3, Scott Bowden 3, Kumar Visvanathan 1 2, Jacinta A Holmes 1 2, Alexander J Thompson 1 2
|
|
|
|
|
|
|
|
|
20. | Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022 |
|
MMWR Morb Mortal Wkly Rep. 2024 Jul 25;73(29):648-655. doi: 10.15585/mmwr.mm7329a3.
Mary M Alleman, Leandro Soares Sereno, Alvaro Whittembury, Xi Li, Marcela Contreras, Carmelita Pacis-Tirso, Martha Velandia Gonzalez, Karen Broome, Sandra Jones, Daniel Salas, Monica Alonso, Rania A Tohme, Annemarie Wasley
|
|
|
|
|
|
|
23. | High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy |
|
Liver Int. 2024 Jul 15. doi: 10.1111/liv.16029. Online ahead of print.
Simon J Hume 1 2 3, Danny K Wong 4, Man-Fung Yuen 4, Kathy Jackson 3, Sara Bonanzinga 3, Sara Vogrin 2, Samuel A L Hall 1 2, Gareth S Burns 5, Paul V Desmond 1, Vijaya Sundararajan 1 2, Dilip Ratnam 6, Miriam T Levy 7, John S Lubel 8, Amanda J Nicoll 9, Simone I Strasser 10, William Sievert 6, Meng C Ngu 11, Marie Sinclair 12, Christopher Meredith 13, Gail Matthews 14, Peter A Revill 3, Margaret Littlejohn 3, Scott Bowden 3, Kumar Visvanathan 1 2, Jacinta A Holmes 1 2, Alexander J Thompson 1 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30. | Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee |
|
Transpl Infect Dis. 2024 Jun 16:e14305. doi: 10.1111/tid.14305. Online ahead of print.
Helen S Te 1, Dong Heun Lee 2, Ann E Woolley 3, Maheen Z Abidi 4, Cynthia Fisher 5, Marty T Sellers 6, Sarah Taimur 7, Taylor Livelli 8, Tamika Watkins 8, Dzhuliyana Handarova 8, Gerald J Berry 9, Riki Graves 10, Chak-Sum Ho 11, Anna L Hughart 12, Michelle Kittleson 13, Charles C Marboe 14, Rachel A Miller 15, Tanvi S Sharma 16, Anil J Trindade 17, R Patrick Wood 18, Lorenzo N Zaffiri 19, Stephanie M Pouch 20, Lara Danziger-Isakov 21
|
|
|
31. | Hepatitis B discrimination: global responses requiring global data |
|
BMC Public Health. 2024 Jun 11;24(1):1575. doi: 10.1186/s12889-024-18918-8.
Catherine Freeland 1, Anousha Qureshi 2, Jack Wallace 3 4 5, Kenneth Kabagambe 6, Hailemichael Desalegn 7, Chris Munoz 8, Dee Lee 9, Theobald Owusu-Ansah 10 11, Danjuma Adda 12 13, Gibril Ndow 13 14, Sarra Yousif 15, Hala Abdalla 15, Omer Kheir 15 16, Thomas Tu 16 17 18, Chari Cohen 2
|
|
|
|
|
33. | Peer support for people living with hepatitis B virus-A foundation for treatment expansion |
|
J Viral Hepat. 2024 May 26. doi: 10.1111/jvh.13952. Online ahead of print.
Louise O Downs 1 2 3, Kenneth Kabagambe 4, Sarah Williams 5, Elizabeth Waddilove 6, Marion Delphin 6, Sheila F Lumley 2 3, Richard Ndungutse 7, Beatrice Kimono 7, Robert Newton 7 8, Joy Ko 9, Emily Martyn 10 11, Jessica Carter 12, Agnieszka Kemper 9, Fernando Monteiro 9, Sive O'Regan 13, Julian Surey 13 14, Binta Sultan 11 14, Alistair Story 13, Douglas MacDonald 15, Thomas Tu 16 17 18 19, Janet Seeley 10 20, Geoffrey Dusheiko 21, Tongai Maponga 22, Monique I Andersson 3 23, C Wendy Spearman 24, Joseph D Tucker 10, Chari Cohen 25, Su Wang 25 26, Danjuma Adda 27 28, Catherine Freeland 25, Rachel Halford 27 29, Kathryn Jack 30, Indrajit Ghosh 9 13, Ahmed M Elsharkawy 31, Philippa C Matthews 6 9 11, Stuart Flanagan 9 11
|
|
|
|
|
35. | Hepatitis B virus and hepatitis C virus affect mitochondrial function through different metabolic pathways, explaining virus-specific clinical features of chronic hepatitis |
|
J Infect Dis. 2024 Apr 24:jiae210. doi: 10.1093/infdis/jiae210. Online ahead of print.
Sakthi Priya Selvamani 1, Anis Khan 1, Enoch S E Tay 1, Matthew Garvey 1, Harout Ajoyan 1, Eve Diefenbach 2, Brian S Gloss 3, Thomas Tu 1, Jacob George 1, Mark W Douglas 1 4
|
|
|
|
|
37. | Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt |
|
J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935. Online ahead of print.
Saleh A Alqahtani 1 2 3, Yusuf Yilmaz 1 4, Mohamed El-Kassas 1 5, Khalid Alswat 1 6, Faisal Sanai 7, May AlZahrani 8, Faisal Abaalkhail 9 10, Manal AlShaikh 8, Waleed K Al-Hamoudi 2 6, Fatema Nader 1 11 12, Maria Stepanova 1 11 12, Zobair M Younossi 1 11 12; Global NASH Council
|
|
|
|
|
39. | Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study |
|
Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4.
Anna-Maria Hartner 1, Xiang Li 2, Susy Echeverria-Londono 2, Jeremy Roth 2, Kaja Abbas 3, Megan Auzenbergs 4, Margaret J de Villiers 2, Matthew J Ferrari 5, Keith Fraser 2, Han Fu 4, Timothy Hallett 2, Wes Hinsley 2, Mark Jit 6, Andromachi Karachaliou 7, Sean M Moore 8, Shevanthi Nayagam 9, Timos Papadopoulos 10, T Alex Perkins 8, Allison Portnoy 11, Quan Tran Minh 8, Emilia Vynnycky 10, Amy K Winter 12, Holly Burrows 13, Cynthia Chen 14, Hannah E Clapham 15, Aniruddha Deshpande 16, Sarah Hauryski 5, John Huber 17, Kevin Jean 18, Chaelin Kim 19, Jong-Hoon Kim 19, Jemima Koh 14, Benjamin A Lopman 16, Virginia E Pitzer 13, Yvonne Tam 20, Philipp Lambach 21, So Yoon Sim 21, Kim Woodruff 2, Neil M Ferguson 2, Caroline L Trotter 22, Katy A M Gaythorpe 23
|
|
|
|
|
|
|
42. | Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN trials |
|
Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000878. Online ahead of print.
Muhammad Atif Zahoor 1, Joshua B Feld 1, Hsing-Hua Sylvia Lin 2, Alexander I Mosa 1, Loghman Salimzadeh 1, Robert P Perrillo 3, Raymond T Chung 4, Kathleen B Schwarz 5, Harry LA Janssen 1 6, Adam J Gehring 1 7, Jordan J Feld 1
|
|
|
|
|
44. | Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study) |
|
Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002759. Online ahead of print.
Grishma Hirode 1 2 3, Bettina E Hansen 1 4 5, Chien-Hung Chen 6, Tung-Hung Su 7, Grace L H Wong 8, Wai-Kay Seto 9, Arno Furquim d'Almeida 10, Margarita Papatheodoridi 11, Sylvia M Brakenhoff 12, Sabela Lens 13, Hannah S J Choi 1, Rong-Nan Chien 14, Jordan J Feld 1 2 3, Xavier Forns 13, Milan J Sonneveld 12, George V Papatheodoridis 11, Thomas Vanwolleghem 10 15, Man-Fung Yuen 9, Henry L Y Chan 8, Jia-Horng Kao 7, Yao-Chun Hsu 16, Markus Cornberg 17, Wen-Juei Jeng 14, Harry L A Janssen 1 12; RETRACT-B study group
|
|
|
|
|
|
|
47. | Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses |
|
JHEP Rep. 2024 Jan 18;6(4):100999. doi: 10.1016/j.jhepr.2023.100999. eCollection 2024 Apr.
Man-Fung Yuen 1, Scott Fung 2, Xiaoli Ma 3, Tuan T Nguyen 4, Tarek Hassanein 5, Hie-Won Hann 6, Magdy Elkhashab 7, Ronald G Nahass 8, James S Park 9, Ira M Jacobson 10, Walid S Ayoub 11, Steven-Huy Han 12, Edward J Gane 13, Katie Zomorodi 14, Ran Yan 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Frank Weilert 16, Alnoor Ramji 17, Michael Bennett 18, Natarajan Ravendhran 19, Sing Chan 20, Douglas T Dieterich 21, Paul Yien Kwo 22, Eugene R Schiff 23, Ho S Bae 24, Jacob Lalezari 25, Kosh Agarwal 26, Mark S Sulkowski 27
|
|
|
48. | Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease |
|
Aliment Pharmacol Ther. 2024 Mar 22. doi: 10.1111/apt.17967. Online ahead of print.
Rohit Loomba 1, Ginger Clark 2, Jeff Teckman 3, Veeral Ajmera 1, Cynthia Behling 1 4, Mark Brantly 5, David Brenner 6, Jeanine D'Armiento 7, Michael W Fried 8, Janani S Iyer 9, Mattias Mandorfer 10, Don C Rockey 11, Monica Tincopa 12, Raj Vuppalanchi 13, Zobair Younossi 14, Aleksander Krag 15, Alice M Turner 16, Pavel Strnad 17
|
|
|
|
|
50. | Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study |
|
Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4.
Anna-Maria Hartner 1, Xiang Li 2, Susy Echeverria-Londono 2, Jeremy Roth 2, Kaja Abbas 3, Megan Auzenbergs 4, Margaret J de Villiers 2, Matthew J Ferrari 5, Keith Fraser 2, Han Fu 4, Timothy Hallett 2, Wes Hinsley 2, Mark Jit 6, Andromachi Karachaliou 7, Sean M Moore 8, Shevanthi Nayagam 9, Timos Papadopoulos 10, T Alex Perkins 8, Allison Portnoy 11, Quan Tran Minh 8, Emilia Vynnycky 10, Amy K Winter 12, Holly Burrows 13, Cynthia Chen 14, Hannah E Clapham 15, Aniruddha Deshpande 16, Sarah Hauryski 5, John Huber 17, Kevin Jean 18, Chaelin Kim 19, Jong-Hoon Kim 19, Jemima Koh 14, Benjamin A Lopman 16, Virginia E Pitzer 13, Yvonne Tam 20, Philipp Lambach 21, So Yoon Sim 21, Kim Woodruff 2, Neil M Ferguson 2, Caroline L Trotter 22, Katy A M Gaythorpe 23
|
|
|
|
|
|
|
|
|
54. | Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy |
|
Drug Saf. 2024 Feb 14. doi: 10.1007/s40264-024-01399-4. Online ahead of print.
Eric B Cohen 1, Arie Regev 2, Anju Garg 3, Adrian M Di Bisceglie 4, James H Lewis 5, John M Vierling 6, Judith Hey-Hadavi 7, Klaudia Steplewski 8, Anna Fettiplace 9, Chunlin L Chen 10, Nonko Pehlivanov 11, Stuart Kendrick 12, Mark I Avigan 13
|
|
|
|
|
|
|
|
|
58. | The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis |
|
Hepatology. 2024 Feb 1;79(2):425-437.doi: 10.1097/HEP.0000000000000563. Epub 2023 Aug 23.
Xiujuan Chang 1, Caihong Lv 1 2, Bingqiong Wang 3, Jing Wang 4, Zheng Song 1 2, Linjing An 1, Shuyan Chen 3, Yongping Chen 5, Qinghua Shang 6, Zujiang Yu 7, Lin Tan 8, Qin Li 9, Huabao Liu 10, Li Jiang 11, Guangming Xiao 12, Liang Chen 13, Wei Lu 14, Xiaoyu Hu 15, Zheng Dong 1, Yan Chen 1, Yameng Sun 3, Xiaodong Wang 5, Zhiqin Li 7, Da Chen 9, Hong You 3, Jidong Jia 3, Yongping Yang 1 2
|
|
|
|
|
|
|
|
|
|
|
63. | Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B |
|
Clin Gastroenterol Hepatol. 2023 Nov;21(12):30893096.e1. doi:10.1016/j.cgh.2023.03.024.Epub 2023 Mar 31.
Lesley A Patmore 1, Warshan K Katwaroe 2, Daniel van der Spek 2, Hannah S J Choi 3, Keyur Patel 3, Sylvia Brakenhoff 2, Adriaan J van der Meer 2, Willem P Brouwer 2, Laurens A van Kleef 2, Rob J de Knegt 2, Bettina E Hansen 4, Rob A de Man 2, Jordan J Feld 4, Harry L A Janssen 5, Milan J Sonneveld 2
|
|
|
|
|
|
|
|
|
|
|
|
|
69. | Chronic Hepatitis B Virus Infection and Risk of Stroke Types: A Prospective Cohort Study of 500 000 Chinese Adults |
|
Stroke. 2023 Dec;54(12):3046-3053. doi: 10.1161/STROKEAHA.123.043327. Epub 2023 Nov 9.
Elizabeth M Hamilton 1, Ling Yang 1 2, Neil Wright 1, Iain Turnbull 1, Alexander J Mentzer 3, Philippa C Matthews 4 5, Yiping Chen 1 6, Huaidong Du 1, Christiana Kartsonaki 1 2, Yuanjie Pang 7, Pei Pei 6, Huizi Tian 8, Xiaoming Yang 1, Daniel Avery 1, Canqing Yu 7 6, Jun Lv 7 6, Robert Clarke 1, Liming Li 7 6, Iona Y Millwood 1 2, Zhengming Chen 1 2
|
|
|
|
|
|
|
|
|
|
|
|
|
75. | What Is the Current Status of Hepatitis B Virus Viro-Immunology? |
|
Clin Liver Dis. 2023 Nov;27(4):819-836. doi: 10.1016/j.cld.2023.05.001.Epub 2023 Jul 4.
Carolina Boni 1, Marzia Rossi 2, Ilaria Montali 2, Camilla Tiezzi 2, Andrea Vecchi 3, Amalia Penna 3, Sara Doselli 2, Valentina Reverberi 3, Camilla Ceccatelli Berti 2, Anna Montali 2, Simona Schivazappa 3, Diletta Laccabue 2, Gabriele Missale 4, Paola Fisicaro 5
|
|
|
|
|
77. | Hepatitis B Virus DNA and Hepatitis B e Antigen Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and Hepatitis B Antigen Loss in Hepatitis B e Antigen-Negative Patients Who Discontinued Antiviral Therapy |
|
Gastroenterology. 2023 Sep 26:S0016-5085(23)05068-0. doi: 10.1053/j.gastro.2023.09.033.Online ahead of print.
Milan Johan Sonneveld 1, Shao-Ming Chiu 2, Jun Yong Park 3, Sylvia M Brakenhoff 4, Apichat Kaewdech 5, Wai-Kay Seto 6, Yasuhito Tanaka 7, Ivana Carey 8, Margarita Papatheodoridi 9, Piero Colombatto 10, Florian van Bömmel 11, Harry L Janssen 4, Thomas Berg 4, Fabien Zoulim 12, Sang Hoon Ahn 3, George N Dalekos 13, Nicole S Erler 14, Maurizia Brunetto 10, Heiner Wedemeyer 15, Markus Cornberg 15, Man-Fung Yuen 6, Kosh Agarwal 8, Andre Boonstra 4, Maria Buti 16, Teerha Piratvisuth 5, George Papatheodoridis 9, Chien-Hung Chen 2, Benjamin Maasoumy 15; CREATE Study Group
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84. | Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants |
|
Hepatol Commun. 2023 Jul 17;7(8):e0188.doi: 10.1097/HC9.0000000000000188. eCollection 2023 Aug 1.
Alexander J Thompson 1 2, Kathy Jackson 3, Sara Bonanzinga 3, Sam A L Hall 1 2, Simon Hume 1 2, Gareth S Burns 1 2, Vijaya Sundararajan 2 4, Dilip Ratnam 5 6, Miriam T Levy 7, John Lubel 8 9, Amanda J Nicoll 10, Simone I Strasser 11 12, William Sievert 5 6, Paul V Desmond 1, Meng C Ngu 13, Marie Sinclair 14, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 3, Margaret Littlejohn 3, D Scott Bowden 3, Jesse A Canchola 17, Jason Torres 17, Philip Siew 18, Jasmin Lau 17, Benjamin La Brot 17, Alison Kuchta 17, Kumar Visvanathan 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92. | Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance |
|
Vox Sang. 2023 Sep 11. doi: 10.1111/vox.13514. Online ahead of print.
Syria Laperche 1 2, Claire Sauvage 3, Pierre Gallian 1, Saadia Jbilou 1, Elodie Pouchol 1, Jean Yves Py 1, Lila Chabli 1, Pascale Richard 1, Pascal Morel 1 4, Florence Lot 3, Pierre Tiberghien 1 4
|
|
|
|
|
|
|
|
|
96. | Chronic Hepatitis B Finite Treatment: similar and different concerns with new drug classes |
|
Clin Infect Dis. 2023 Aug 26;ciad506. doi: 10.1093/cid/ciad506. Online ahead of print.
Marion G Peters 1, Man-Fung Yuen 2, Norah Terrault 3, John Fry 4, Pietro Lampertico 5, Ed Gane 6, Carey Hwang 7, Luisa M Stamm 8, Mitchell Leus 9, Mala K Maini 10, Patricia Mendez 11, Isabelle Lonjon-Domanec 12, Thomas Berg 13, Su Wang 14, Poonam Mishra 15, Eric Donaldson 15, Stephanie Buchholz 16, Veronica Miller 9, Oliver Lenz 17
|
|
|
|
|
|
|
99. | Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus |
|
JHEP Rep. 2023 Apr 24;5(8):100777. doi: 10.1016/j.jhepr.2023.100777.eCollection 2023 Aug.
Philippa C Matthews 1 2 3, Ponsiano Ocama 4, Su Wang 5 6, Manal El-Sayed 7, Anna Turkova 8, Deborah Ford 8, Judith Torimiro 9 10, Ana Cristina Garcia Ferreira 11, Angélica Espinosa Miranda 11, Fernando Pio De La Hoz Restrepo 12, Emmanuel Seremba 4, Robinson Mbu 10, Calvin Q Pan 13, Homie Razavi 14, Geoffrey Dusheiko 15, C Wendy Spearman 16, Saeed Hamid 17
|
|
|
|
|
|
|
|
|
103. | Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance |
|
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1957-1959. doi: 10.1016/j.cgh.2022.06.019.Epub 2022 Jul 16.
Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6; HBRN HBV NOVELASSAYS GROUP
Collaborators
- HBRN HBV NOVELASSAYS GROUP:
Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
|
|
|
|
|
|
|
106. | Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020 |
|
Am J Prev Med. 2023 Jul;65(1):52-59. doi: 10.1016/j.amepre.2023.01.041. Epub 2023 Mar 10.
Thi T Hang Pham 1, Nimisha Maria 1, Vivian Cheng 1, Brandon Nguyen 1, Mehlika Toy 1, David Hutton 2, Erin E Conners 3, Noele P Nelson 3, Joshua A Salomon 4, Samuel So 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
115. | Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States |
|
J Viral Hepat. 2023 Jul 24. doi: 10.1111/jvh.13874. Online ahead of print.
Nicole D Ferrante 1 2, Michael J Kallan 3, Sophia Sukkestad 4, Maja Kodani 4, Mari M Kitahata 5, Edward R Cachay 6, Debika Bhattacharya 7, Sonya Heath 8, Sonia Napravnik 9, Richard D Moore 10, George Yendewa 11, Kenneth H Mayer 12 13, K Rajender Reddy 1, Tonya Hayden 4, Saleem Kamili 4, Jeffrey N Martin 14, H Nina Kim 5, Vincent Lo Re 3rd 2 15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128. | Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study |
|
Liver Int. 2023 May;43(5):989-999. doi: 10.1111/liv.15531. Epub 2023 Feb 16.
Jessica Howell 1 2, Huy Van 1, Minh D Pham 1 3, Rohit Sawhney 2 4 5, Fan Li 1, Purnima Bhat 6, John Lubel 7, William Kemp 7, Stephen Bloom 4 5, Avik Majumdar 8, Geoffrey W McCaughan 8 9, Samuel Hall 2, Timothy Spelman 1, Joseph S Doyle 1 10, Margaret Hellard 1 10, Kumar Visvanathan 2, Alexander Thompson 2, Heidi E Drummer 1 11 12, David Anderson 1
|
|
|
129. | Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™ |
|
J Viral Hepat. 2023 Apr;30(4):335-344. doi: 10.1111/jvh.13800. Epub 2023 Jan 11.
Zobair M Younossi 1 2 3, Ming-Lung Yu 4 5, Yusuf Yilmaz 6 7, Khalid Aida Alswat 8, Maria Buti 9, Marlen Ivon Castellanos Fernandez 10, Georgios Papatheodoridis 11, Saeed S Hamid 12, Mohamed El-Kassas 13, Wah Kheong Chan 14, Ajay K Duseja 15, Stuart C Gordon 16, Yuichiro Eguchi 17, Vasily A Isakov 18, Stuart K Roberts 19 20, Jian-Gao Fan 21, Ashwani K Singal 22, Manuel Romero-Gómez 23, Aijaz Ahmed 24, Janus Ong 25, Brian P Lam 1 2 3, Issah Younossi 26, Fatema Nader 26, Andrei Racila 26, Maria Stepanova 1 2 3 26, Saleh Alqahtani 26 27
|
|
|
130. | Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial |
|
Am J Gastroenterol. 2023 May 5. doi: 10.14309/ajg.0000000000002176. Online ahead of print.
Jordan J Feld 1 2, Abdus S Wahed 3 4, Michael Fried 5, Marc G Ghany 6, Adrian M Di Bisceglie 7, Robert P Perrillo 8, Mandana Khalili 9, Xue Yang 3, Steven H Belle 3 4, Harry L A Janssen 1 2, Norah Terrault 10, Anna S Lok 11; Hepatitis B Research Network (HBRN)
|
|
|
131. | Pathway to global elimination of hepatitis B: HBV cure is just the first step |
|
Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000430. Online ahead of print.
Jessica Howell 1 2 3 4, Chris Seaman 1 4, Jack Wallace 1, Yinzong Xiao 1, Nick Scott 1, Jane Davies 5, Teresa de Santis 5, Danjuma Adda 6, Manal El-Sayed 7, Jordan J Feld 8, Edward Gane 9, Karine Lacombe 10, Olufunmilayo Lesi 11, Rosmawati Mohamed 12, Marcelo Silva 13, Thomas Tu 14 15, Peter Revill 16, Margaret E Hellard 1 4 17 18
|
|
|
132. | Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB |
|
Hepatology. 2023 Apr 20. doi: 10.1097/HEP.0000000000000413. Online ahead of print.
Marc G Ghany 1, Wendy C King 2, Amanda S Hinerman 3, Anna Sf Lok 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Norah Terrault 7, Harry L A Janssen 8, Mandana Khalili 9, William M Lee 10, Daryl T Y Lau 11, Gavin A Cloherty 12, Richard K Sterling 13
|
|
|
|
|
|
|
|
|
136. | Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database |
|
J Infect. 2023 May;86(5):476-485. doi: 10.1016/j.jinf.2023.03.001. Epub 2023 Mar 9.
Anna Maria Geretti 1, Harrison Austin 2, Giovanni Villa 3, Colette Smith 4, Caroline Sabin 5, Ruby Tsang 6, Julian Sherlock 6, Filipa Ferreira 6, Rachel Byford 6, Bernardo Meza-Torres 6, Martin Whyte 6, Simon de Lusignan 6
|
|
|
137. | Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease |
|
Vaccine. 2023 May 11;41(20):3224-3232. doi: 10.1016/j.vaccine.2023.04.028.Epub 2023 Apr 19.
Matthias Girndt 1, Patricia Houser 2, Roberto Manllo-Karim 3, John E Ervin 4, Chaim Charytan 5, Stephen Chow 6, Margarita Symonian-Silver 7, Lawrence Lehrner 8, Douglas Linfert 9, Douglas Shemin 10, Ann Michelsen 11, Fang Xie 12, Robert S Janssen 13
|
|
|
|
|
139. | Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis |
|
Hepatology. 2023 Apr 1;77(4):1348-1365. doi: 10.1002/hep.32731. Epub 2022 Sep 16.
Dimitri Loureiro 1 2, Issam Tout 1 2, Stéphanie Narguet 1 2, Cheikh Mohamed Bed 1 2, Morgane Roinard 1 2, Ahmad Sleiman 1 2, Nathalie Boyer 1 2, Nathalie Pons-Kerjean 3, Corinne Castelnau 1 2, Nathalie Giuly 1 2, Dorothy Tonui 1 2, Vassili Soumelis 4 5, Jamel El Benna 1, Patrick Soussan 6, Richard Moreau 1 2, Valérie Paradis 1 2, Abdellah Mansouri 1 2, Tarik Asselah 1 2
|
|
|
|
|
141. | Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis |
|
Surg Res. 2023 Mar;283:1078-1090. doi: 10.1016/j.jss.2022.10.078.Epub 2022 Dec 15.
Colin C Yost 1, Diana C Jimenez 1, Matthew P Weber 1, Elizabeth J Maynes 1, Katherine A Belden 2, Vakhtang Tchantchaleishvili 1, H Todd Massey 1, David A Sass 3, J Eduardo Rame 4, John J Zurlo 2, Nana Aburjania 5
|
|
|
142. | Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities |
|
Am J Transplant. 2023 Apr 26;S1600-6135(23)00428-8. doi: 10.1016/j.ajt.2023.04.024.Online ahead of print.
Anshul Bhatnagar 1, Sameer Prakash 2, Peter Lymberopoulos 3, Cameron Goff 1, Anjiya Shaikh 4, Donghee Kim 5, Aijaz Ahmed 5, Carl Berg 6, Susanna Naggie 7, Fasiha Kanwal 8, George Cholankeril 9, Tzu-Hao Lee 10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150. | Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center |
|
United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376.Epub 2023 Mar 25.
Mathias Jachs 1, Raphael Sauberer 1, Alexander Stiegler 1, Anton Dechêne 1, Raphael Tazreiter 1, Lukas Hartl 1, David Bauer 1, Lorenz Balcar 1, Robert Strassl 2, Mattias Mandorfer 1, Michael Trauner 1, Petra Munda 1, Peter Ferenci 1, Thomas Reiberger 1
|
|
|
151. | A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B |
|
J Hepatol. 2023 May;78(5):926-936.doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28.
Florian van Bömmel 1, Kerstin Stein 2, Renate Heyne 3, Jörg Petersen 4, Peter Buggisch 4, Christoph Berg 5, Stefan Zeuzem 6, Andreas Stallmach 7, Martin Sprinzl 8, Eckart Schott 9, Anita Pathil-Warth 10, Ulrike von Arnim 11, Verena Keitel 12, Jürgen Lohmeyer 13, Karl-Georg Simon 14, Christian Trautwein 15, Andreas Trein 16, Dietrich Hüppe 17, Markus Cornberg 18, Frank Lammert 19, Patrick Ingiliz 20, Reinhart Zachoval 21, Holger Hinrichsen 22, Alexander Zipprich 23, Hartmuth Klinker 24, Julian Schulze Zur Wiesch 25, Anett Schmiedeknecht 26, Oana Brosteanu 26, Thomas Berg 27
|
|
|
|
|
|
|
154. | Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States |
|
Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.
Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
|
|
|
|
|
|
|
|
|
158. | Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial |
|
Sex Transm Infect. 2023 Mar;99(2):140-142.doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8.
Paul Le Turnier 1 2 3, Isabelle Charreau 4, Audrey Gabassi 5 6, Diane Carette 4, Laurent Cotte 7, Gilles Pialoux 8, Cécile Tremblay 9, Bruno Spire 10, Marie-Laure Chaix 5 6, Laurence Meyer 4 11, Catherine Capitant 4, Constance Delaugerre 5 6, François Raffi # 12 2, Jean-Michel Molina # 6 13; ANRS IPERGAY study group
|
|
|
|
|
|
|
|
|
162. | Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination |
|
Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006.Epub 2023 Feb 13.
Giuseppina Brancaccio 1, Barbara Coco 2, Alessandra Nardi 3, Maria Giovanna Quaranta 4, Maria Elena Tosti 4, Luigina Ferrigno 4, Irene Cacciola 5, Vincenzo Messina 6, Luchino Chessa 7, Filomena Morisco 8, Michele Milella 9, Francesco Barbaro 10, Alessia Ciancio 11, Francesco Paolo Russo 12, Nicola Coppola 13, Pierluigi Blanc 14, Ernesto Claar 15, Gabriella Verucchi 16, Massimo Puoti 17, Anna Linda Zignego 18, Liliana Chemello 19, Salvatore Madonia 20, Stefano Fagiuoli 21, Alfredo Marzano 22, Carlo Ferrari 23, Pietro Lampertico 24, Vito Di Marco 25, Antonio Craxì 26, Teresa Antonia Santantonio 27, Giovanni Raimondo 5, Maurizia R Brunetto 2, Giovanni Battista Gaeta 28, Loreta A Kondili 29; PITER collaborating investigators
|
|
|
163. | Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature |
|
Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780.eCollection 2023.
Cesare Mazzaro 1, Riccardo Bomben 1, Marcella Visentini 2, Laura Gragnani 3, Luca Quartuccio 4, Francesco Saccardo 5, Marco Sebastiani 6, Davide Filippini 7, Gianfranco Lauletta 8, Giuseppe Monti 5, Valter Gattei 1
|
|
|
|
|
|
|
|
|
|
|
168. | Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection |
|
Gut. 2023 Jan 25;gutjnl-2022-328041. doi: 10.1136/gutjnl-2022-328041. Online ahead of print.
Harry L A Janssen 1 2, Jinlin Hou 3, Tarik Asselah 4, Henry L Y Chan 5, Fabien Zoulim 6, Yasuhito Tanaka 7, Ewa Janczewska 8, Ronald G Nahass 9, Stefan Bourgeois 10, Maria Buti 11, Pietro Lampertico 12 13, Oliver Lenz 14, Thierry Verbinnen 14, Joris Vandenbossche 14, Willem Talloen 14, Ronald Kalmeijer 15, Maria Beumont 15, Michael Biermer 16, Umesh Shukla 15
|
|
|
|
|
170. | Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B |
|
Dig Dis. 2023;41(1):115-123. doi: 10.1159/000526933. Epub 2022 Sep 7.
Daniel Q Huang 1 2, Dong Hyun Lee 3 4, Michael H Le 4, An Le 4, Yee Hui Yeo 4, Huy N Trinh 5, Mimi Chung 6, Vy Nguyen 4, Tiffani Johnson 7, Jian Q Zhang 8, Clifford Wong 9, Christopher Wong 9, Jiayi Li 10, Ramsey Cheung 4 11, Mindie H Nguyen 4
|
|
|
171. | Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure |
|
Gut. 2023 Jan 27;gutjnl-2022-328380. doi: 10.1136/gutjnl-2022-328380. Online ahead of print.
Lena Allweiss 1 2, Barbara Testoni 3 4, Mei Yu 5, Julie Lucifora 3 4 6, Chunkyu Ko 7 8, Bingqian Qu 9 10, Marc Lütgehetmann 2 11, Haitao Guo 12 13, Stephan Urban 2 9, Simon P Fletcher 5, Ulrike Protzer 2 7, Massimo Levrero 3 4, Fabien Zoulim 14 4, Maura Dandri 15 2
|
|
|
|
|
|
|
|
|
175. | Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes |
|
Diabetologia. 2022 Jul;65(7):1108-1118. doi: 10.1007/s00125-022-05701-w. Epub 2022 Apr 30.
Clemens Kamrath 1, Sascha R Tittel 2 3, Desiree Dunstheimer 4, Elke Fröhlich-Reiterer 5, Markus Freff 6, Claudia Böttcher 7, Nadine Scheffler 8, Stefanie Lenze 9, Elke Gericke 10, Susanne Thiele 11, Reinhard W Holl 2 3
|
|
|
|
|
|
|
|
|
|
|
180. | Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways |
|
J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Benjamin J Mooney 2, Rosemary Millen 2, Rachel Morris 2, Sara Vogrin 2, Vijaya Sundararajan 3, Dilip Ratnam 4, Miriam T Levy 5, John S Lubel 6 7, Amanda J Nicoll 8, Simone I Strasser 9 10, William Sievert 4 11, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, Scott Bowden 17, Stephen A Locarnini 17, Alexander J Thompson 1 2, Kumar Visvanathan 1 2
|
|
|
|
|
|
|
| | | | | |